SCHEMBL7304285

SCHEMBL7304285

C=C(Br)CC(NC(C)=O)(C(=O)O)C(=O)O

nearest known ligand 0.35

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.35
KDM4E B2RXH2 1/20 0.35
THRB P10828 1/20 0.34
HTT P42858 1/20 0.33
ALDH1A1 P00352 1/20 0.32
RECQL P46063 1/20 0.32
TET2 Q6N021 1/20 0.31
MEN1 O00255 1/20 0.31
MAPT P10636 1/20 0.31
KMT2A Q03164 1/20 0.31
ATM Q13315 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7333555 0.80 PKM (0.35) PKMKDM4ETHRBHTTALDH1A1
SCHEMBL22775064 0.77 PKM (0.62) PKMKDM4ETHRBHTTALDH1A1
SCHEMBL7295778 0.76 PKM (0.35) PKMKDM4ETHRBHTTALDH1A1
SCHEMBL3402649 0.69 PKM (0.36) PKMKDM4ETHRBHTTALDH1A1
SCHEMBL16571690 0.68 PKM (0.42) PKMKDM4ETHRBHTTALDH1A1
SCHEMBL28369972 0.67 TET2 (0.41) KDM4EALDH1A1TET2
SCHEMBL8301912 0.65 PKM (0.36) PKMKDM4ETHRBHTTALDH1A1
SCHEMBL7421934 0.64 PKM (0.35) PKMKDM4ETHRBHTTALDH1A1
SCHEMBL9978380 0.64 PKM (0.35) PKMKDM4ETHRBHTTALDH1A1
SCHEMBL7421930 0.64 PKM (0.35) PKMKDM4ETHRBHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5523289-A RENIN INHIBITOR ABBOTT LABORATORIES (US) 1996-06-04 US disclosed
EP-0456185-B1 Renin inhibitors ABBOTT LAB (US) 1995-05-31 EP disclosed
US-5344990-A Process for the preparation of a renin inhibiting compound ABBOTT LABORATORIES (US) 1994-09-06 US disclosed
US-5310740-A Congestive heart failure, hypotensive agents, antiglaucoma agents; side effect reduction ABBOTT LABORATORIES (US) 1994-05-10 US disclosed
US-5284849-A Treating hypertension and congestive heart failure ABBOTT LABORATORIES (US) 1994-02-08 US disclosed
US-5275950-A Process for the preparation of a renin inhibiting compound ABBOTT LABORATORIES (US) 1994-01-04 US disclosed
US-5276031-A Method for treating renal disease ABBOTT LABORATORIES (US) 1994-01-04 US disclosed
US-5258362-A Enzyme inhibitors, amides with oxetane ring ABBOTT LABORATORIES (US) 1993-11-02 US disclosed
WO-1993007886-A1 PHARMACEUTICAL COMPOSITION CONTAINING CERTAIN PEPTIDOMIMETIC COMPOUNDS ABBOTT LABORATORIES (US) 1993-04-29 WO disclosed
WO-1993002667-A1 PHARMACEUTICAL COMPOSITION ABBOTT LABORATORIES (US) 1993-02-18 WO disclosed
US-5182266-A Method for treating renal disease ABBOTT LABORATORIES (US) 1993-01-26 US disclosed
US-5178877-A Cardiovascular disorders ABBOTT LABORATORIES (US) 1993-01-12 US disclosed
US-5122514-A Administering renin inhibitor ABBOTT LABORATORIES (US) 1992-06-16 US disclosed
EP-0456185-A2 Renin inhibitors ABBOTT LABORATORIES (US) 1991-11-13 EP disclosed
US-5063208-A Cardiovascular disorders, vision defects ABBOTT LABORATORIES (US) 1991-11-05 US disclosed
EP-0440102-A1 Method for treating renal disease ABBOTT LABORATORIES (US) 1991-08-07 EP disclosed
EP-0410260-A2 Peptidyl aminodiol renin inhibitors ABBOTT LABORATORIES (US) 1991-01-30 EP disclosed